NCT06975293 2026-03-05STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced CancersSTORM Therapeutics LTDPhase 1/2 Recruiting188 enrolled
NCT06984588 2026-01-30A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung CancerTJ Biopharma Co., Ltd.Phase 2/3 Active not recruiting450 enrolled